Relief Therapeutics (RLFTF) Short Interest Ratio & Short Volume $2.63 -0.08 (-2.77%) As of 04/1/2025 10:36 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartFinancialsSEC FilingsShort InterestBuy This Stock Relief Therapeutics Short Interest DataRelief Therapeutics (RLFTF) has a short interest of 400 shares. This marks a 300.00% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 2,438 shares to cover all short positions.Current Short Interest400 sharesPrevious Short Interest100 sharesChange Vs. Previous Month+300.00%Dollar Volume Sold Short$1,264.00Short Interest Ratio0.1 Days to CoverLast Record DateMarch 15, 2025Today's Trading Volume329 sharesAverage Trading Volume2,438 sharesToday's Volume Vs. Average13% Short Selling Relief Therapeutics? Sign up to receive the latest short interest report for Relief Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRLFTF Short Interest Over TimeRLFTF Days to Cover Over TimeRLFTF Percentage of Float Shorted Over Time Remove Ads Relief Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2025400 shares $1,264.00 +300.0%N/A0.1 $3.16 2/28/2025100 shares $345.00 No ChangeN/A0 $3.45 1/31/2025100 shares $405.50 -88.9%N/A0 $4.06 1/15/2025900 shares $3,883.14 +80.0%N/A0.1 $4.31 12/31/2024500 shares $2,327.60 -28.6%N/A0.1 $4.66 12/15/2024700 shares $3,003.00 -41.7%N/A0.1 $4.29 11/30/20241,200 shares $6,717.60 +140.0%N/A0.2 $5.60 11/15/2024500 shares $3,470.00 -28.6%N/A0 $6.94 10/31/2024700 shares $4,410.00 -56.3%N/A0.2 $6.30 10/15/20241,600 shares $10,320.00 No ChangeN/A0.1 $6.45 Get the Latest News and Ratings for RLFTF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relief Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/15/20241,000 shares $2,540.00 No ChangeN/A0.1 $2.54 7/15/2024100 shares $129.00 No ChangeN/A0.1 $1.29 6/30/2024100 shares $132.50 No ChangeN/A0.1 $1.33 5/31/20241,500 shares $2,280.00 +650.0%N/A0.7 $1.52 5/15/2024200 shares $284.00 -90.0%N/A0 $1.42 4/30/20242,000 shares $2,800.00 +17.7%N/A0.6 $1.40 4/15/20241,700 shares $2,244.00 -82.3%N/A0.4 $1.32 3/31/20249,600 shares $13,920.00 +123.3%N/A1.1 $1.45 3/15/20244,300 shares $6,708.00 +2.4%N/A0.7 $1.56 2/29/20244,200 shares $7,350.00 +121.1%N/A1.1 $1.75 2/15/20241,900 shares $3,686.00 -59.6%N/A0.2 $1.94 11/30/2023100 shares $228.00 No ChangeN/A0.1 $2.28 10/31/2023800 shares $1,880.00 -20.0%N/A0.2 $2.35 10/15/20231,000 shares $2,390.00 -69.7%N/A0.2 $2.39 9/30/20233,300 shares $7,920.00 +22.2%N/A0.4 $2.40 9/15/20232,700 shares $7,425.00 -38.6%N/A0.2 $2.75 8/31/20234,400 shares $13,772.00 +10.0%N/A0.3 $3.13 8/15/20234,000 shares $10,360.00 +3,900.0%N/A0.5 $2.59 7/31/2023100 shares $300.00 -88.9%N/A0 $3.00 7/15/2023900 shares $2,862.00 -97.8%N/A0.1 $3.18 6/30/202341,300 shares $128,649.50 +13.8%N/A2.3 $3.12 6/15/202336,300 shares $145,200.00 No ChangeN/A2.6 $4.00 4/30/202356,500 shares $406,800.00 +13.7%N/A0 $7.20 4/15/202349,700 shares $1,023.82 -47.1%N/A0 $0.02 3/31/202393,900 shares $2,131.53 -34.8%N/A0.1 $0.02 3/15/2023144,100 shares $2,882.00 +297.0%N/A0.1 $0.02 2/28/202336,300 shares $954.69 -40.8%N/A0 $0.03 2/15/202361,300 shares $1,569.28 +68.9%N/A0 $0.03 1/31/202336,300 shares $1,143.45 No ChangeN/A0 $0.03 1/15/202336,300 shares $1,187.01 -27.8%N/A0 $0.03Partner with Elon Musk on Project Colossus… Before May 1st (Ad)Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.Click here to see how you could take a stake in Elon’s private company… 12/30/202250,300 shares $1,473.79 +38.6%N/A0 $0.03 12/15/202236,300 shares $1,132.56 No ChangeN/A0 $0.03 11/15/2022290,700 shares $9,593.10 -20.9%N/A0.1 $0.03 10/31/2022367,600 shares $9,484.08 +25.1%N/A0.3 $0.03 10/15/2022293,900 shares $7,788.35 -83.8%N/A0.2 $0.03 9/30/20221,812,800 shares $49,489.44 +180.9%N/A0.8 $0.03 9/15/2022645,400 shares $22,201.76 +92.7%N/A0.3 $0.03 8/31/2022335,000 shares $11,348.13 -24.6%N/A0.2 $0.03 8/15/2022444,100 shares $16,387.29 +41.0%N/A0.2 $0.04 7/31/2022314,900 shares $10,785.33 -3.3%N/A0.1 $0.03 7/15/2022325,600 shares $11,884.40 -79.2%N/A0.1 $0.04 6/30/20221,563,800 shares $50,542.02 +396.1%N/A0.4 $0.03 6/15/2022315,200 shares $9,613.60 -96.4%N/A0.1 $0.03 5/31/20228,783,900 shares $382,978.04 +27.8%N/A0.7 $0.04 5/15/20226,873,900 shares $364,316.70 -8.9%N/A2.7 $0.05 4/30/20227,546,300 shares $382,974.73 +86.2%N/A2.1 $0.05 4/15/20224,052,200 shares $262,987.78 +43.7%N/A1 $0.06 3/31/20222,819,200 shares $197,062.08 -10.2%N/A1 $0.07 3/15/20223,138,900 shares $215,328.54 -48.5%N/A0.7 $0.07 2/28/20226,096,300 shares $432,837.30 +46.5%N/A1.8 $0.07 2/15/20224,161,300 shares $331,655.61 +36.2%N/A1.5 $0.08 1/31/20223,054,700 shares $229,102.50 +3.2%N/A1 $0.08 1/15/20222,961,300 shares $264,147.96 -6.3%N/A0.3 $0.09 12/31/20213,159,500 shares $205,051.55 -19.4%N/A0.3 $0.06 12/15/20213,917,500 shares $255,029.25 -3.0%N/A0.7 $0.07 11/30/20214,039,000 shares $273,844.20 +32.9%N/A0.5 $0.07 11/15/20213,039,800 shares $214,913.86 +37.5%N/A0.1 $0.07 10/29/20212,210,200 shares $197,591.88 +9.3%N/A0.2 $0.09 10/15/20212,021,500 shares $238,537.00 -49.7%N/A0.1 $0.12 9/30/20214,021,100 shares $597,133.35 -0.9%N/A0.5 $0.15 9/15/20214,059,300 shares $678,106.07 -15.3%N/A0.4 $0.17 8/31/20214,790,000 shares $967,580.00 +6.8%N/A0.6 $0.20 8/13/20214,483,600 shares $981,908.40 -5.9%N/A0.5 $0.22 7/30/20214,762,200 shares $1.15 million +366.6%N/A0.3 $0.24 7/15/20211,020,600 shares $198,608.76 +4.5%N/A0.2 $0.19 6/30/2021976,700 shares $216,339.05 -54.4%N/A0.2 $0.22 6/15/20212,142,300 shares $0.00 -20.0%N/A0.3 $0.00 5/28/20212,678,800 shares $605,341.83 -43.2%N/A0.3 $0.23 5/14/20214,718,600 shares $1.01 million -24.7%N/A0.4 $0.21 4/30/20216,266,700 shares $1.54 million -33.6%N/A0.4 $0.25 4/15/20219,431,600 shares $2.72 million +2.7%N/A1 $0.29 3/31/20219,184,300 shares $3.09 million +25.1%N/A0.6 $0.34 3/15/20217,343,600 shares $2.20 million -5.8%N/A0.6 $0.30 2/26/20217,792,100 shares $3.03 million +141.2%N/A0.3 $0.39 2/12/20213,230,400 shares $1.24 million +27.1%N/A0.1 $0.38 1/29/20212,541,200 shares $1.45 million +42.3%N/A0.2 $0.57 1/15/20211,792,700 shares $641,786.60 -14.0%N/A0.2 $0.36 12/31/20201,967,800 shares $610,018.00 +9.8%N/A0.2 $0.31 12/15/20201,792,700 shares $812,093.10 -14.0%N/A0.2 $0.45 11/30/20202,084,000 shares $924,254.00 -28.1%N/A0.1 $0.44Partner with Elon Musk on Project Colossus… Before May 1st (Ad)Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.Click here to see how you could take a stake in Elon’s private company… 11/15/20202,899,800 shares $1.03 million -9.2%N/A0.1 $0.36 10/30/20203,193,900 shares $1.68 million +24.5%N/A0.3 $0.53 10/15/20202,565,800 shares $1.44 million -9.5%N/A0.3 $0.56 9/30/20202,834,200 shares $1.51 million -24.3%N/A0.2 $0.53 9/15/20203,744,500 shares $1.90 million +126.3%N/A0.3 $0.51 8/31/20201,654,800 shares $0.00 +183.0%N/A0 $0.00 RLFTF Short Interest - Frequently Asked Questions What is Relief Therapeutics' current short interest? Short interest is the volume of Relief Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 400 shares of RLFTF short. Learn More on Relief Therapeutics' current short interest. Is Relief Therapeutics' short interest increasing or decreasing? Relief Therapeutics saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 400 shares, an increase of 300.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Relief Therapeutics stock? Short selling RLFTF is an investing strategy that aims to generate trading profit from Relief Therapeutics as its price is falling. RLFTF shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Relief Therapeutics? A short squeeze for Relief Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RLFTF, which in turn drives the price of the stock up even further. How often is Relief Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLFTF, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies TRSBF Short Interest Data AGTX Short Interest Data AGNPF Short Interest Data APLMW Short Interest Data ASPHF Short Interest Data AVCTF Short Interest Data AWKNF Short Interest Data AXIM Short Interest Data BCTXW Short Interest Data CDIOW Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:RLFTF) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relief Therapeutics Holding SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Relief Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
